Histiocytosis
📧 Sign up to get email alerts when something new happens for Histiocytosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Histiocytic Disorder Follow-up Study
A University of Alabama at Birmingham-sponsored clinical trial update indicates recruiting for a histiocytic disorder follow-up study, inclu…
-
CLINICAL_TRIALS trial_result · 2025-01-24Clinical Trial Update: Cobimetinib for BRAF-wild-type or Mutated Histiocytoses [Phase 3]
Phase 3 clinical trial evaluating cobimetinib for histiocytoses (BRAF-wild-type or mutated) has completed. The update does not provide trial…
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant [Phase 2]
Phase 2 clinical trial update on CD34+ selection for partially matched family or matched unrelated adult donor transplants in leukemia and l…
-
CLINICAL_TRIALS trial_result · 2017-04-17Clinical Trial Update: Ceftriaxone in Non-neutropenic Fever
A completed clinical trial evaluating ceftriaxone for non-neutropenic fever in pediatric patients with histiocytosis and cancer.
-
CLINICAL_TRIALS trial_result · 2015-12-14Clinical Trial Update: HLA-Nonidentical Stem Cell and Natural Killer Cell Transplantation for Children Less the Two Years of Age With Hematologic Malignancies [Phase 2]
Phase 2 trial evaluating HLA-nonidentical stem cell and natural killer cell transplantation in children under two with hematologic malignanc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: Unrelated Donor Transplant for Malignant and Non-Malignant Disorders [Phase 2]
Phase 2 trial of unrelated donor transplantation for malignant and non-malignant hematologic disorders; the study status is terminated.